Baricitinib may be the superior choice to tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis (RA) for whom conventional synthetic disease-modifying antirheumatic drugs ...

Please provide your email address to receive an email when new articles are posted on . Patients treated with TNF inhibitors had respiratory hospitalization and mortality rates similar to patients on ...

Drug retention was similar with second-line IL-17 inhibitors vs TNF inhibitors in patients with axial spondyloarthritis who discontinued their initial TNF inhibitor, though IL-17 inhibitors showed ...

Intelligen Therapeutics Co. Ltd. and Intelligen Therapeutics Inc. have disclosed macrocyclic compounds acting as TNF-α inhibitors reported to be useful for the treatment of inflammation and autoimmune ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Although TNF inhibitors remain the first choice biologic ...

ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors, ...

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease. A new study published recently in the journal Gut shows children with Crohn's who ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas, a particularly debilitating complication of Crohn's ...

Exposure to TNF inhibitors was associated with a reduced risk for new-onset depression among patients with ankylosing spondylitis. Tumor necrosis factor (TNF) inhibitor therapy is associated with a ...

Newswise — Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas, a particularly debilitating complication of ...